Evolent Health Inc Class A Com (EVH) 22.76 $EVH Business

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Evolent Health Inc Class A Com (EVH) 22.76 $EVH

Business Talent Group Closes Series B Funding led by NextEquity Partners to Accelerate Firm's Leadership in the Fast-Growing Market for Independent Professionals
PR Newswire - Mon Sep 12, 7:00AM CDT
Business Talent Group (BTG), the leading platform for top independent consultants and executives doing project-based work, announced today that it has closed an $8 million Series B funding round led by NextEquity Partners. The round also includes participation from David and Katherine Bradley through the Bradley Family Trust; Ted Meisel, the former CEO of Overture and co-founder of AVIA Health Innovation; and numerous existing investors. NextEquity Managing Director Adam Hopkins will join BTG's board as will Frank Williams, CEO of Evolent Health and former CEO and Chairman of The Advisory Board Company. Ted Meisel and NextEquity Principal Rami Reyes, will join as board observers.
EVH: 22.76 (-0.04)

Evolent Health, Inc. Announces Pricing of Upsized Secondary Public Offering of Class A Common Stock
PR Newswire - Thu Sep 08, 8:59PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ("Evolent Health", today announced the pricing of a secondary public offering of 7,500,000 shares of its Class A common stock to be sold by UPMC, certain affiliates of TPG Global, LLC, The Advisory Board Company and Ptolemy Capital, LLC (together, the "Investor Stockholders" and certain management selling stockholders (the "Management Stockholders" and together with the Investor Stockholders, the "Selling Stockholders". The shares of Class A common stock are being sold to the public at a price of $22.50 per share. The offering was upsized from the previously announced offering size of 7,000,000 shares of Class A common stock. The underwriters have a 30-day option period to purchase up to 1,125,000 additional shares of Class A common stock from the Investor Stockholders. The offering is expected to close on September 14, 2016, subject to customary closing conditions.
JPM: 67.25 (-0.14), EVH: 22.76 (-0.04), WFC: 45.74 (+0.02)

Evolent Health, Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
PR Newswire - Tue Sep 06, 3:01PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ("Evolent Health", today announced the launch of an underwritten secondary public offering of 7,000,000 shares of its Class A common stock to be sold by UPMC, certain affiliates of TPG Global, LLC, The Advisory Board Company and Ptolemy Capital, LLC (together, the "Investor Stockholders" and certain management selling stockholders (the "Management Stockholders" and together with the Investor Stockholders, the "Selling Stockholders". The underwriters have a 30-day option period to purchase up to 1,050,000 additional shares of Class A common stock from the Investor Stockholders.
JPM: 67.25 (-0.14), EVH: 22.76 (-0.04), WFC: 45.74 (+0.02)

Evolent Health Partners with St. Luke's Health Partners to Enhance Care Delivery in Idaho
PR Newswire - Thu Aug 04, 3:20PM CDT
Evolent Health, Inc (NYSE: EVH), and St. Luke's Health Partners announced today that they have entered into a definitive agreement for a multi-year operating partnership. The collaboration between the two organizations will guide the development and execution of a value-based care strategy for improving the health of patients across the care delivery network of St. Luke's Health System, the largest locally-owned health system in the state of Idaho.
EVH: 22.76 (-0.04)

Evolent Health Announces Second Quarter 2016 Results
PR Newswire - Thu Aug 04, 3:19PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced financial results for the quarter ended June 30, 2016.
EVH: 22.76 (-0.04)

Evolent Health to Participate in Upcoming Investor Conferences
PR Newswire - Thu Jun 02, 1:00PM CDT
Evolent Health, Inc. (NYSE: EVH) ("Evolent", a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, Seth Blackley, President and Co-Founder, Nicky McGrane, CFO, and Steve Wigginton, Chief Development Officer, will participate in upcoming investor conferences.
EVH: 22.76 (-0.04)

Chasm Partners Places New CEO for Remedy Partners
PRWeb - Thu May 26, 3:06AM CDT
Chasm Partners, a leading retained search firm focused exclusively on health technology and services, announced today the placement of Carolyn Magill as the new CEO of its client, Remedy Partners. Chasm Partners was selected earlier this year to lead the CEO search for Remedy Partners.
EVH: 22.76 (-0.04)

Evolent Health to Host Investor and Analyst Day on May 25, 2016
PR Newswire - Fri May 20, 8:42AM CDT
Evolent Health, a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, will host its first Investor and Analyst Day on Wednesday, May 25, 2016 at its headquarters in Arlington, VA.
EVH: 22.76 (-0.04)

Evolent (EVH) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri May 13, 7:14AM CDT
Evolent (EVH) reported loss of 24 cents per share, wider than the Zacks Consensus Estimate of a loss of 19 cents.
EVH: 22.76 (-0.04), MDSO: 56.51 (-0.08), QSII: 11.49 (unch), ATHN: 123.83 (-0.79)

Evolent Health Partners with Georgia Physicians for Accountable Care to Improve Clinical Outcomes in the Southeast
PR Newswire - Thu May 12, 4:34PM CDT
Evolent Health (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, announced today its partnership with Georgia Physicians for Accountable Care (GPAC). The partnership will guide the development and execution of a value-based care strategy for improving patient health in Georgia.
EVH: 22.76 (-0.04)

Evolent Health Announces First Quarter 2016 Results
PR Newswire - Thu May 12, 3:15PM CDT
Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced financial results for the quarter ended March 31, 2016.
EVH: 22.76 (-0.04)

Internet Stocks' Q1 Earnings on May 12: EVH, LTRPA, UPLD
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:44AM CDT
Among the companies slated to report this week, let's see what's ahead for these three Internet stocks, all of which are slated to release their first-quarter 2016 numbers on May 12.
EVH: 22.76 (-0.04), UPLD: 8.97 (+0.05), GOOGL: 814.96 (-0.99), MSFT: 57.43 (-0.39), LTRPA: 21.21 (+0.12), AAPL: 112.71 (-1.91)

Evolent Health, Inc. to Release First Quarter Operating Results and Host Conference Call on Thursday, May 12, 2016
PR Newswire - Thu Apr 28, 1:00PM CDT
Evolent Health, Inc. (NYSE: EVH) ("Evolent" will release its first quarter operating results on Thursday, May 12, 2016 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.
EVH: 22.76 (-0.04)

Evolent Health Launches Identifi 5.0, Enabling Actionable Insights for Extended Care Teams
PR Newswire - Wed Feb 10, 8:00AM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent", a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, is pleased to announce the successful launch of IdentifiSM 5.0. Identifi is purpose-built as a provider-led operating platform for health systems entering, managing or growing value-based contracts and provider-sponsored health plans. The latest platform upgrades, including the launch of the Identifi Practice application, bring critical patient insights and a holistic patient view directly to the point of care.
EVH: 22.76 (-0.04)

Evolent Health to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
PR Newswire - Fri Feb 05, 2:00PM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent", a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, and Nicky McGrane, CFO, will present at the upcoming LEERINK Partners 5th Annual Global Healthcare Conference in New York.
EVH: 22.76 (-0.04)

Passport Health Plan and Evolent Health form Strategic Alliance to create Medicaid Center of Excellence in Louisville
PR Newswire - Tue Feb 02, 8:00AM CST
Passport Health Plan and Evolent Health are pleased to announce the formation of a strategic alliance that will create The Medicaid Center of Excellence.
EVH: 22.76 (-0.04)

Evolent Health to Present at the 34th Annual J.P. Morgan Healthcare Conference
PR Newswire - Tue Dec 29, 1:00PM CST
Evolent Health, Inc. (NYSE: EVH) ("Evolent", a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Frank Williams, CEO and Co-Founder, and Nicky McGrane, CFO, will present at the upcoming 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
JPM: 67.25 (-0.14), EVH: 22.76 (-0.04)

A Refreshing Outlook - Analyst Notes on Unisys, Central Garden & Pet, Evolent Health and Crawford & Co
ACCESSWIRE - Mon Dec 28, 7:10AM CST
NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Unisys Corp. (NYSE: UIS), Central Garden & Pet Co. (NASDAQ: CENTA), Evolent Health Inc. (NYSE: EVH) and Crawford & Co. (NYSE: CRD.B). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
EVH: 22.76 (-0.04), CENTA: 24.39 (+0.36), UIS: 9.45 (+0.04), CRD.B: 11.09 (-0.22)

Traders Look to Upside - New Reports on Amkor Technology, A10 Networks, Stemline Therapeutics and Evolent Health
ACCESSWIRE - Thu Dec 24, 6:31AM CST
NEW YORK, NY / ACCESSWIRE / December 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Amkor Technology Inc. (NASDAQ: AMKR), A10 Networks Inc. (NYSE: ATEN), Stemline Therapeutics Inc. (NASDAQ: STML) and Evolent Health Inc. (NYSE: EVH). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
AMKR: 9.13 (-0.26), EVH: 22.76 (-0.04), STML: 10.58 (+0.35), ATEN: 10.53 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immuron Advances IMM-529 Development Following FDA Feedback

Updated Category News Views 289

Immuron Charts Path for Phase 2 Trial of IMM-529 Key Highlights Immuron concludes an important pre-IND meeting with the FDA regarding IMM-529, aimed at combating Clostridioides difficile infection (CDI). Previous clinical trials highlight the necessity for ongoing development of IMM-529. The company plans to submit an IND application for IMM-529 in the first half of 2025.

Continue Reading
Enefit Green to Host Webinars for Unveiling 2024 Results

Updated Category News Views 123

Join Enefit Green's Upcoming Webinars on 2024 Results Enefit Green is set to announce its Q4 and annual unaudited results for 2024. The special reveal will occur shortly after the publication of the report, allowing shareholders and investors to gain critical insights into the company's financial standing. Webinar Schedule and Details The webinars will be hosted on the...

Continue Reading
Intapp's Encouraging Earnings Fuel Stock Surge Amid Market Momentum

Updated Category News Views 197

Intapp's Strong Earnings Report Captivates Investors On a positive note for investors, U.S. stocks saw an uplifting day, with the Dow Jones index climbing approximately 250 points. The highlight of the day was the impressive performance of Intapp, Inc. Shares of Intapp, Inc. (NASDAQ: INTA) experienced a sharp increase following the company's announcement of...

Continue Reading
NewAmsterdam Pharma's Upcoming Conference Participation for 2024

Updated Category News Views 229

NewAmsterdam Pharma Announces Conference Participation NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is gearing up for an exciting lineup of presentations at key medical and investor conferences. As a leader in developing innovative oral therapies for cardiovascular disease, NewAmsterdam is set to share groundbreaking research findings and engage with stakeholders in...

Continue Reading
John Hancock Funds Announce Monthly Distribution Updates

Updated Category News Views 366

Monthly Distribution Announcements from John Hancock Funds John Hancock has announced important updates regarding the distributions for its closed-end funds. These monthly distributions aim to provide returns to investors, ensuring they receive value from their investments in a timely manner. Details of the Monthly Distribution Declaration Key Dates Recently, the board of...

Continue Reading